Literature DB >> 3455748

Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.

W P Newman, D S Freedman, A W Voors, P D Gard, S R Srinivasan, J L Cresanta, G D Williamson, L S Webber, G S Berenson.   

Abstract

We assessed the relation of risk factors for cardiovascular disease to early atherosclerotic lesions in the aorta and coronary arteries in 35 persons (mean age at death, 18 years). Aortic involvement with fatty streaks was greater in blacks than in whites (37 vs. 17 percent, P less than 0.01). However, aortic fatty streaks were strongly related to antemortem levels of both total and low-density lipoprotein cholesterol (r = 0.67, P less than 0.0001 for each association), independently of race, sex, and age, and were inversely correlated with the ratio of high-density lipoprotein cholesterol to low-density plus very-low-density lipoprotein cholesterol (r = -0.35, P = 0.06). Coronary-artery fatty streaks were correlated with very-low-density lipoprotein cholesterol (r = 0.41, P = 0.04). Mean systolic blood-pressure levels also tended to be higher in the four subjects with coronary-artery fibrous plaques than in those without them: 112 mm Hg as compared with 104 (P = 0.09). These results document the importance of risk-factor levels to early anatomical changes in the aorta and coronary arteries. The progression of fatty streaks to fibrous plaques is uncertain, but these data suggest that a rational approach to the prevention of cardiovascular disease should begin early in life.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3455748     DOI: 10.1056/NEJM198601163140302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  136 in total

1.  Around PediHeart: hyperlipidemia.

Authors:  F McCaffrey
Journal:  Pediatr Cardiol       Date:  2001 Jan-Feb       Impact factor: 1.655

Review 2.  Physical activity guidelines for children and adolescents: a critical review.

Authors:  J W Twisk
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Framingham risk score is associated with femoral artery intima-media thickness in asymptomatic young adults (the Bogalusa heart study).

Authors:  Timir K Paul; Wei Chen; Sathanur R Srinivasan; Janet Rice; Ahmet Toprak; Jiang He; Gerald S Berenson
Journal:  Atherosclerosis       Date:  2010-10-20       Impact factor: 5.162

4.  Preventive cardiology for pediatric atherogenesis.

Authors:  J T Bricker
Journal:  Tex Heart Inst J       Date:  1992

5.  Cohort Profile: the international childhood cardiovascular cohort (i3C) consortium.

Authors:  Terence Dwyer; Cong Sun; Costan G Magnussen; Olli T Raitakari; Nicholas J Schork; Alison Venn; Trudy L Burns; Markus Juonala; Julia Steinberger; Alan R Sinaiko; Ronald J Prineas; Patricia H Davis; Jessica G Woo; John A Morrison; Stephen R Daniels; Wei Chen; Sathanur R Srinivasan; Jorma Sa Viikari; Gerald S Berenson
Journal:  Int J Epidemiol       Date:  2012-03-20       Impact factor: 7.196

Review 6.  Cardiovascular disease risk factors: a childhood perspective.

Authors:  Pradeep A Praveen; Ambuj Roy; Dorairaj Prabhakaran
Journal:  Indian J Pediatr       Date:  2012-05-27       Impact factor: 1.967

Review 7.  Bias in estimating caloric expenditure from physical activity in children. Implications for epidemiological studies.

Authors:  J F Sallis; M J Buono; P S Freedson
Journal:  Sports Med       Date:  1991-04       Impact factor: 11.136

Review 8.  Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

Authors:  Jonathan Wagner; J Steven Leeder
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

9.  Pulse wave reflection in children: amplification through the lifecourse.

Authors:  Justin P Zachariah
Journal:  J Hypertens       Date:  2017-07       Impact factor: 4.844

Review 10.  Cardiovascular disease risk factors and atherosclerosis in children and adolescents.

Authors:  S R Daniels
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.